long intergenic non-protein coding RNA 2393Genealiases: []
Q-omics provides the consensus-scored LINC02393 profile across patient tissues and cancer cell-line models. LINC02393 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, LINC02393 is differentially expressed in 5, with the highest sampling consensus in HNSC. Additionally, LINC02393 RNA expression shows 9,755 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KICH, HNSC, and TGCT as cancer lineages where LINC02393 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02393 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02393 survival associations across molecular data types. LINC02393 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02393 RNA expression–survival associations across cancer types. High LINC02393 expression shows unfavorable associations in KICH, ACC, COAD, PAAD, OV and READ. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for LINC02393 RNA expression.
This table summarizes LINC02393 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02393. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02393 shows higher tumor expression in HNSC, LUSC, LUAD, KIRC and KICH. The HNSC box plot shows higher LINC02393 RNA expression in tumor versus normal tissue (log2 FC = +0.066, t-test p = .003).
This table shows molecular features associated with LINC02393 in patient tissues and cancer cell lines. In patient samples, LINC02393 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
